Poland· PL-100006761

Apitussic

A guaiacolsulfonate product containing sulfogaiacolum, registered in Poland by Farmina Sp. z o.o..

ATC R05CA09

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedApitussicATCR05CA09REGISTER NO.PL-100006761PACKS LISTED1CHECKEDSeptember 27, 2026

The record

At a glance

URPL (Poland)
Active substance
Sulfogaiacolum
Manufacturer
Farmina Sp. z o.o.
Country
Poland (PL)
ATC code
R05CA09
ATC class
Guaiacolsulfonate
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990049912

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under R05CA09

Guaiacolsulfonate, as other registers publish it.

All guaiacolsulfonate products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8971f1d1-3027-4f6b-b421-b2317e4a7b95
GET /v1/drugs/8971f1d1-3027-4f6b-b421-b2317e4a7b95?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Syrop",
  "source": "urpl",
  "strength": "52 mg/5 ml",
  "packaging": "05909990049912 ¦ OTC ¦ 991\n1 butelka 120 ml",
  "substance": "Sulfogaiacolum 0.8 g",
  "common_name": "Sulfogaiacolum",
  "pl_product_id": "100006761",
  "pozwolenie_nr": "00499",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about guaiacolsulfonate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.